1. Vinayagamoorthy D, Walsh J, Gipson K, Ye F, Zhong M, Dahui Q, Vinayagamoorthy T. Detecting EGFR mutations (L858R, T790M) using allele specific multiplex sequencing: A comparison with Pyrosequencing and TruSeq. 2020, Vol. 10, No. 1, p19-24. DOI:
  2. Thurai Moorthy, Chrishanthi Rajasooriyar, Anusha Ginige, Niluka Ranatunge, Rajendra Surenthirakumaran. Effect of significant incidence of Braf p.V600E mutations in esophageal cancer on potential use of tyrosine kinase inhibitors.
  3. Vinayagamoorthy T, Dahui Q, Ye F, Zhong M. Detection of EGFR deletion using RepSeqID technology. BioRxIV. doi:
  4. Moorthy T. Improving Detection of Somatic Mutations. J Cancer Res Therap Oncol 2019 | Vol 7: 101
  5. Moorthy T. Targeted therapy: a potential oversight in trial protocol. Lancet Oncology. Volume 19, Issue 9,  September 01, 2018.
  6. Vinayagamoorthy T, An algorithm to evaluate the efficacy of detecting somatic mutations. Journal of Solid Tumors 2018, Vol. 8, No. 2.
  7. Vinayagamoorthy T, Zhang D, Ye F, Vinayagamoorthy D, Hodkinson R. Can detection of Braf p.V600E mutation be improved? Comparison of allele specific multiplex sequencing to present tests. Journal of Solid Tumors 2017. Vol. 7, No. 2
  8. Yo J, Hay K, Vinayagamoorthy D, Maryanski D, Carter M, Wiegel J, Vinayagamoorthy T. Detection of BRAF mutations from solid tumors using TumorPlexTM technology. MethodsX 2 (2015) 316–322.
  9. Vinayagamoorthy T, Maryanski D, Vinayagamoorthy D, Hay K, Yo J, Carter M, Wiegel J. Improved internal control for molecular diagnostic assays. MethodsX 2 (2015) 159–164.